Zenara Pharma Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
- Paid Up Capital ₹ 48.24 Cr
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.85 Cr
- Satisfied Charges ₹ 16.04 Cr
- Revenue Growth 76.50%
- Profit Growth 148.60%
- Ebitda 96.92%
- Net Worth 17.04%
- Total Assets 29.77%
About Zenara Pharma
Zenara Pharma Private Limited (ZPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 March 2004 and has a history of 20 years and ten months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Danmed Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 48.24 Cr.
The company currently has active open charges totaling ₹2.85 Cr. The company has closed loans amounting to ₹16.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Zenara Pharma Private Limited India are Sri Yanamandra as COMPANY SECRETARY and Srinivas Arutla as Ceo. Jagadeesh Rangisetty and Manikreddy Pullagurla serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239TG2004PTC042894
-
Company No.
042894
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Mar 2004
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Zenara Pharma Private Limited offer?
Zenara Pharma Private Limited offers a wide range of products and services, including Bakery & Confectionery Products, Candy & Jelly.
Who are the key members and board of directors at Zenara Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sri Yanamandra
|
Company Secretary | 20-Jan-2023 | Current |
| Srinivas Arutla | CEO | 01-Jun-2022 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Jagadeesh Rangisetty
|
Director | 21-Jan-2017 | Current |
|
Manikreddy Pullagurla
|
Director | 21-Jan-2017 | Current |
Financial Performance of Zenara Pharma.
Zenara Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 76.5% increase. The company also saw a substantial improvement in profitability, with a 148.6% increase in profit. The company's net worth Soared by an impressive increase of 17.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenara Pharma?
In 2023, Zenara Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Azico Biophore India Private LimitedJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
-
Leiutis Pharmaceuticals LlpJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
-
Biophore India Pharmaceuticals Private LimitedJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
-
Alithia Pharmaceuticals Private Limited
Jagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
-
Sionc Pharmaceuticals Private LimitedJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
-
Envozyme Feeds Private LimitedJagadeesh Rangisetty is a mutual person
Charges (Loans)
₹2.85 Cr
₹16.04 Cr
Charges Breakdown by Lending Institutions
- Others : 2.85 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2017 | Others | ₹2.85 Cr | Open |
| 31 Aug 2021 | Others | ₹5.74 Cr | Satisfied |
| 24 Jun 2005 | The South Indian Bank Limited | ₹10.30 Cr | Satisfied |
How Many Employees Work at Zenara Pharma?
Zenara Pharma has a workforce of 205 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenara Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenara Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
